Enzyme Replacement Therapy Market - Top Companies and Manufacturers

Companies Dominating the Enzyme Replacement Therapy Landscape

BioMarin
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Leadiant Biosciences, Inc.
Pfizer Inc.
Sanofi Aventis
AbbVie Inc.
Takeda Pharmaceutical Company Limited
JCR Pharmaceutical Co., Ltd.
AstraZeneca plc
Clinigen Limited
Teijin Limited

Browse Key Market Insights with Data Illustration:

Enzyme Replacement Therapy Market Size, Growth Forecasts 2037

In the News

Teijin Limited announced the immediate availability of Revcovi 2.4 mg for intramuscular injection [Elapegademase (Genetic Recombination)]. With Revcovi 2.4 mg, Japan's first medication for Adenosine Deaminase (ADA) Deficiency, individuals with ADA Deficiency are expected to have improved ADA activity and immune system.
Clinigen Limited, a global pharmaceutical Products, and Services company, announced that Clinigen K.K., a fully owned subsidiary of Clinigen located in Tokyo, has gained manufacturing and marketing authorization for Hunterase (Idursulfase-beta) ICV 15mg as part of its strategic relationship with GC Pharma. The clearance of Hunterase ICV in Japan marks its first appearance in any nation globally.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of enzyme replacement therapy is assessed at USD 12.03 billion.

The enzyme replacement therapy market size was valued at USD 11.42 billion in 2024 and is anticipated to reach USD 26.48 billion by the end of 2037, registering around 6.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by rise in prevalence of rare disease, growing government spending on healthcare infrastructure, growing cases of Pompe disease, and others.

Asia Pacific industry is set to dominate majority revenue share by 2037, owing to growing number of patient population suffering from rare disorders along with rising disposable income, growth in the healthcare sector, and an increase in government support in the region.

The major players in the market include BioMarin, Leadiant Biosciences, Inc., Pfizer Inc., Sanofi Aventis, AbbVie Inc., Takeda Pharmaceutical Company Limited, JCR Pharmaceutical Co., Ltd., AstraZeneca plc, Clinigen Limited, Teijin Limited.

Enzyme Replacement Therapy Market - Top Companies and Manufacturers

Companies Dominating the Enzyme Replacement Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the enzyme replacement therapy market worth?

Why is the demand for enzyme replacement therapy growing?

Which region dominated the majority of enzyme replacement therapy industry share?

Who are the top enzyme replacement therapy companies?